Authors
Latest:
Zev Wainberg on Combination Chemotherapy Regimens in Metastatic Pancreatic CancerZev A. Wainberg, MD, discusses the implications of the findings from the phase 3 NAPOLI 3 trial for patients with metastatic pancreatic ductal adenocarcinoma.
Latest:
Expert Discusses Best Practices for Managing Breast Cancer–Related ToxicitiesCharles L. Loprinzi, MD, discusses the efficacy of agents like gabapentin and olanzapine to combat breast cancer treatment-related pains and speaks to the future of nonestrogenic toxicity management within this space.
Latest:
Empower Your Clinical Staff to Meet the Growing Patient VolumeOncology practices can create more access to care by leveraging the use of APPs, empowering nurses to practice at the top of their licensure, utilizing nurse navigators, and planning ahead.
Latest:
Elizabeth Cullen Discusses Avasopasem Manganese As A Potential Mucositis Management Strategy in Head and Neck CancersElizabeth R. Cullen, MSN, ARNP, provides an overview of avasopasem manganese and its potential role in reducing severe oral mucositis for patients undergoing radiotherapy.
Latest:
Medical Cannabis 101: What Oncology Nurses Need to KnowWith nearly two-thirds of the states allowing for medical cannabis use and the legalization of hemp, accessing cannabinoids has become much easier— especially for patients with cancer.
Latest:
Mary Katherine Montes de Oca on Cryocompression Therapy For Peripheral Neuropathy in Gynecologic CancersMary Katherine Montes de Oca, MD, discusses the potential benefit of cryocompression therapy in preventing peripheral neuropathy in patients with gynecologic cancers who are receiving chemotherapy.
Latest:
Advances in Head and Neck Cancers Yield New Clinical Implications for NursesAs the treatment paradigm continues to evolve, nurses play a key role in educating patients, monitoring treatments, and watching for adverse effects.
Latest:
Nurses May Advise Patients on Immunotherapy to Increase Fiber IntakeAn expert from The University of Texas MD Anderson Cancer Center offers advice on the best diet to enrich a patient’s microbiome and consequent immunotherapy response.
Latest:
Cancer Care More Accessible Thanks to Launch of Telehealth and In-Home Infusion programsChevon Rariy, MD, outlines patient eligibility criteria, and the alterations to the nurse patient relationship, as CTCA launches the novel Oncology Clinic at Home Program.
Latest:
Sylvester’s Sexual Health After Cancer Program Expands to Meet Needs of Women with CancerKristin E. Rojas, M.D., FACS, FACOG, assistant professor of surgical oncology in the DeWitt Daughtry Department of Surgery and Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine, realized she had struck a chord with women being treated for cancer when she started the Menopause Urogenital Sexual Health and Intimacy Clinic (MUSIC).
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT CareTia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.
Latest:
Darolutamide Combination May Delay Disease Progression in Metastatic Hormone-Sensitive Prostate CancerAdding darolutamide to androgen deprivation therapy and docetaxel delayed the progression from metastatic hormone-sensitive prostate cancer to metastatic castration-resistant disease.
Latest:
Overcoming The Burden of Guilt as A NurseJanice Post-White, PhD, RN, FAAN, an oncology nurse and caregiver, discusses how she handled the guilt she felt following her son’s leukemia diagnosis.
Latest:
Mehra Details the Importance of PD-L1 Expression in HNSCC Treatment SelectionRanee Mehra, MD, discusses the link between PD-L1 expression and increased immunotherapy efficacy in head and neck squamous cell carcinoma, and what future treatment options may look like for patients in this space.
Latest:
Advanced Practice Providers Are Uniquely Suited for Survivorship CareAdvanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.
Latest:
Unmet Needs and Future Directions in the Management of CIMMartin Dietrich, MD, PhD, and Edgardo Santos, MD, FACP, offer closing remarks on unmet needs and future directions in the management of CIM including other disease states where trilaciclib may offer myeloprotective benefit.
Latest:
Onvansertib Combo Appears Efficacious in KRAS+ Metastatic Colorectal CancerThe combination of onvansertib plus FOLFIRI/bevacizumab showed promise among patients with KRAS-mutated metastatic colorectal cancer.
Latest:
Advancing CML Management Towards an Ideal Patient JourneyThe panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.
Latest:
Key Takeaways for Patients With MyelofibrosisPatients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.
Latest:
Colorectal Cancer Screening: Education, Advocacy, and ActionIt is essential to continue to develop and incorporate educational strategies to increase screening for colorectal cancer in our communities.
Latest:
Discrepancies Exist Between Actual Care and Trial-Based Recommendations in MCLDiscrepancies exist between actual patterns of care and recommendations based on clinical trials in adult patients with mantle cell lymphoma.
Latest:
Cancer Vaccine Sparks Immune Response in TNBCMost patients with triple-negative breast cancer experienced a protocol-defined immune response with an investigational vaccine, phase 1 data showed.
Latest:
Oncology Drug Crash Course: Tucatinib and Trastuzumab for HER2+ CRCTucatinib was first approved by the FDA for the treatment of patients with HER2-positive advanced unresectable or metastatic breast cancer in combination with trastuzumab and capecitabine on April 17, 2020.
Latest:
T-Cell Engagers Take Center Stage in Large B-Cell LymphomaBispecific antibodies that engage T cells are an effective treatment modality in relapsed/refractory disease and are an important new treatment for relapsed large B-cell lymphoma.
Latest:
Opinion: Now Is the Time to Optimize Electronic Health Record SystemsBuying one for your practice or enhancing the one you have will help you cut costs and boost your financial stability.
Latest:
Kristin Daly on the Difference Between Somatic and Germline Variants in Precision OncologyKristin M. Daly, MSN, ANP-BC, AOCNP, highlights the difference between somatic and germline variants.
Latest:
Cleveland Clinic Opens New Cancer Center in Abu DhabiThe state-of-the-art facility represents the organization’s vision of global cancer care
Latest:
Oncology Drug Crash Course: Pirtobrutinib (Jaypirca)Sharon Kauffman, PhD, RN, CNE, NPD-BC, OCN, provides an in-depth look at pirtobrutinib in a downloadable reference sheet.
Latest:
Innovative Program Reduces Nurse Turnover and Fosters DevelopmentThe US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.
